Biochefa Pharmaceutical Research and Production Plantsp. z o.o.
Manufacture of basic pharmaceutical products
Overview
Financials
Revenue history (in k)
Filing timeliness
1 of 5 financial statements was filed late (for 2023, 8 days late).
- 2025filed
- 202415/05/2025
- 202323/07/2024
- 202219/04/2023
- 202129/06/2022
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Trademarks
Biochefa Pharmaceutical Research and Production Plant holds 1 active trademark registered with the Polish Patent Office. The first mark was filed in 2021.
| Mark | Number | Classes | Status | Protected until | |
|---|---|---|---|---|---|
| Biochefa Pharmaceutical Research and Production Plant | Z.528266 | 5 | Protected | Apr 29, 2031 |
| Mark | Protected until | |
|---|---|---|
| Biochefa Pharmaceutical Research and Production Plant | Apr 29, 2031 |
Authorized Representatives
Manner of representation
In the case of a one-person management board, the member of the management board makes declarations on behalf of the company. In the case of a management board consisting of two or more persons, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Marcin Damian Magielaage 47 | 70 | $945.43 | 70% |
Krzysztof Piotr Rosakage 56 | 30 | $405.19 | 30% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2021-02-13.
53 1020 2401 0000 0102 0605 7790- 33 1020 2401 0000 0602 0605 7808
Debt
No entries in the National Debtors Register (KRZ).
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jun 22, 2023 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $423$423 | Prezydent Miasta Sosnowiec |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Biotriosp. z o.o. | $453,662.22 | biotrio.pl | ||
| Inner Harmonysp. z o.o. | $434,516.06 | innerharmony.pl | ||
| Biocanto Pharmasp. z o.o. | $186,097.96 | biocanto.pl | ||
| Nature's Voicesp. z o.o. | $181,977.76 | naturesvoice.eu | ||
| Vilowaysp. z o.o. | $175,174.05 | viloway.com | ||
| Rohto-Mentholatum Europesp. z o.o. | $129,196.95 | rohto.pl | ||
| Pexon Polandsp. z o.o. | $122,615.96 | pexon.pl | ||
| Agro-Sorbsp. z o.o. | $98,845.83 | agro-sorb.com | ||
| Bioresearch PharmaS.A. | $76,294.71 | bioresearchpharma.com | ||
| Amorphis Pharma Developmentsp. z o.o. | $35,766.66 | amorphispharma.com |
FAQ
Last updated: 2026-04-24